Mode
Text Size
Log in / Sign up

Peripheral nerve stimulation significantly reduces tremor intensity and functional disability in essential tremorNerve stimulation reduces essential tremor in short term

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider peripheral nerve stimulation for essential tremor to reduce tremor intensity and improve functional outcomes.

This meta-analysis evaluated the efficacy of peripheral nerve stimulation (PNS) for patients with essential tremor. The analysis included 914 participants and focused on primary outcomes including tremor intensity measured by the TETRAS Performance Scale, as well as secondary outcomes such as functional disability and clinical improvement.

The synthesis reported a statistically significant reduction in tremor intensity (MD=-0.92; 95%CI [-1.63 to -0.21], P=0.01, I2=0). Additionally, patients showed significant improvements in functional outcomes on the Bain and Findley Activities of Daily Living scale (MD=-1.90; 95%CI [-2.97 to -0.83], p=0.0005, I2=0). Safety data indicated an acceptable safety profile with mild, limited adverse events such as transient skin irritation; no serious adverse events were reported.

Limitations noted by the authors include small sample sizes and inconsistent outcome reporting across studies. The authors emphasize that larger, longer randomized trials with refined sham controls are necessary to confirm efficacy, durability, and optimal stimulation strategies. PNS may serve as a middle ground option between pharmacotherapy and invasive neurosurgical approaches for managing essential tremor.

How this fits prior evidence

This meta-analysis addresses a gap in non-invasive management options for essential tremor. It provides an alternative to the surgical interventions previously covered, such as Vim-targeted tremor surgery and staged bilateral MRgFUS thalamotomy. While those procedures offer significant improvement or consistent results, PNS may serve as a middle ground between pharmacotherapy and invasive neurosurgical approaches.

For people with essential tremor, the uncontrollable shaking can make simple tasks like eating or writing a daily struggle. Medications don't always work well, and brain surgery is a big step. Now a new analysis of existing studies suggests there may be a middle ground: peripheral nerve stimulation (PNS), a noninvasive treatment that uses mild electrical pulses to calm the nerves.

The meta-analysis looked at 914 patients across several trials and found that PNS led to a statistically significant reduction in tremor intensity, measured on a standard scale. People also reported improvements in functional disability, meaning they could do everyday activities more easily. The effects lasted up to three months.

Safety was a plus: side effects were mild and limited mainly to temporary skin irritation. No serious adverse events were reported. However, the researchers caution that the studies were small and used different ways of measuring outcomes. They say larger, longer trials with better sham controls are needed to confirm how well PNS works and how long the benefits last.

Still, for someone looking for an option between pills and surgery, PNS might offer a promising path forward.

What this means for you:
Peripheral nerve stimulation may offer a safe, noninvasive option for short-term tremor relief.

Common questions

What is peripheral nerve stimulation for essential tremor?

Peripheral nerve stimulation (PNS) is a noninvasive treatment that uses mild electrical pulses to calm nerves. It is applied to the skin, often on the wrist or arm, and may help reduce shaking and improve daily function in people with essential tremor.

Is peripheral nerve stimulation safe for essential tremor?

In the studies reviewed, side effects were mild and limited mainly to temporary skin irritation. No serious adverse events were reported. The analysis describes the safety profile as acceptable, but larger and longer studies are needed to confirm long-term safety.

How well does peripheral nerve stimulation work for essential tremor?

The meta-analysis found a statistically significant reduction in tremor intensity and improvement in functional disability over up to three months. However, the studies were small and used different outcome measures, so more research is needed to confirm the results.

Who might benefit from peripheral nerve stimulation for essential tremor?

PNS may be an option for people with essential tremor who do not get enough relief from medication or who want to avoid invasive brain surgery. It is considered a middle ground between pills and surgery. Talk to your doctor to see if it is right for you.

Study Details

Study typeMeta analysis
Sample sizen = 914
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Essential tremor (ET) is a common movement disorder; its management remains challenging despite the availability of multiple treatment options. Pharmacological therapies are often limited in efficacy and tolerability, while surgical options, although effective, are invasive and expensive. Peripheral nerve stimulation (PNS) has emerged as a non-invasive neuromodulation approach. However, different stimulation protocols, small samples, and inconsistent outcome reporting preclude firm conclusions. Therefore, we performed a systematic review and meta-analysis to evaluate the efficacy and safety of PNS for ET. A literature search was conducted through PubMed, Scopus, Web of Science, and Cochrane CENTRAL databases till January 2026. The primary outcome was the change in tremor intensity, as measured by the TETRAS Performance Scale (TETRAS-PS). Secondary outcomes included functional disability, assessed by the Bain and Findley Activities of Daily Living (BF-ADL) scale, clinical improvement assessed using the clinical global impression - improvement (CGI-I) scale, as well as safety outcomes. Quality assessment was performed using the Risk of Bias-2 (RoB-2) and the NIH single-arm tools. Certainty of evidence was assessed using GRADE approach. A meta-analysis was performed, calculating the mean difference (MD) with 95% confidence intervals (CIs) using Review Manager 5.4.1. Twelve studies, involving 914 participants, met the inclusion criteria, including four RCTs. Our analysis of RCTs demonstrated that active PNS produced a statistically significant reduction in tremor intensity (TETRAS-PS; MD=-0.92, 95%CI [-1.63 to -0.21], P = 0.01, I2 = 0) and an improvement in functional outcomes (BF-ADL; MD=-1.90, 95%CI [-2.97 to -0.83], p = 0.0005, I2 = 0). Benefits were observed immediately and persisted for up to three months in longitudinal studies. Adverse events were generally mild and limited mainly to transient skin irritation; no device-related serious adverse events were reported. PNS was associated with short-term reduction in tremor severity and functional impairment in patients with ET, with an overall acceptable safety profile, suggesting that it may serve as a middle ground option between pharmacotherapy and invasive neurosurgical approaches. However, further larger and longer randomized trials with refined sham controls are needed to confirm its efficacy, durability, and optimize stimulation strategies. CRD420261282826.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.